Annual Drug Patent Expirations for FIRVANQ+KIT
Firvanq Kit is a drug marketed by Azurity and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug.
Drug patent litigation for FIRVANQ KIT.
This drug has nine patent family members in seven countries.
The generic ingredient in FIRVANQ KIT is vancomycin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
